As of 2026-03-24, the Intrinsic Value of National Health Investors Inc (NHI) is 98.94 USD. This NHI valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 82.32 USD, the upside of National Health Investors Inc is 20.20%.
The range of the Intrinsic Value is 56.17 - 267.21 USD
Based on its market price of 82.32 USD and our intrinsic valuation, National Health Investors Inc (NHI) is undervalued by 20.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 56.17 - 267.21 | 98.94 | 20.2% |
| DCF (Growth 10y) | 60.82 - 260.41 | 101.53 | 23.3% |
| DCF (EBITDA 5y) | 65.16 - 78.03 | 73.12 | -11.2% |
| DCF (EBITDA 10y) | 72.65 - 92.56 | 83.70 | 1.7% |
| Fair Value | 16.95 - 16.95 | 16.95 | -79.41% |
| P/E | 71.30 - 86.85 | 78.91 | -4.1% |
| EV/EBITDA | 44.59 - 73.62 | 57.15 | -30.6% |
| EPV | 21.95 - 36.78 | 29.37 | -64.3% |
| DDM - Stable | 35.33 - 141.49 | 88.41 | 7.4% |
| DDM - Multi | 39.66 - 108.69 | 56.50 | -31.4% |
| Market Cap (mil) | 3,983.46 |
| Beta | 0.17 |
| Outstanding shares (mil) | 48.39 |
| Enterprise Value (mil) | 5,127.65 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.85% |
| Cost of Debt | 4.97% |
| WACC | 6.12% |